Shooting the breeze on ADO, page-2285

For the impatient a brief reminder

Commercialisation pathway for AnteoX Cross Linked Binder for Lithium-Ion batteries There has been a significant expansion in commercial engagement with counterparties during the period from 10 collaborators to 26 highly credible counterparties spanning the battery value chain from global chemical companies to battery manufacturers to OEMs. In addition, good progress is being made with our existing commercial partners in advancing the technical validation of AnteoX. Most recently, separate technical validations were conducted by a global battery manufacturer and Japanese battery developer, ENAX Inc. During FY22, ENAX Inc confirmed that the inclusion of AnteoX cross-linked binder technology in its reference battery design resulted in a 45% improvement in cycle life. The results of this testing reinforce AnteoX’s electrochemical performance-enhancing properties in lithium-ion batteries using high silicon content anodes. The results achieved by the global battery manufacturer further confirmed that AnteoX significantly enhanced binder effectiveness across multiple battery binder types, resulting in improved capacity retention. Heading into FY23, AnteoTech will be working with numerous counterparties as they continue their evaluations and development work incorporating AnteoX within their proprietary battery and binder systems.

“Financial Year 2022 was a year in which our team delivered a number of crucial R&D outcomes, setting the Company up with an exciting commercialisation opportunity. Establishing a clinically backed development pathway for the group’s diagnostic testing platform, EuGeni, required extensive engagement with regulatory bodies, development partners and investors across multiple jurisdictions, which is a testament to the skills and teamwork of the whole organisation. Pleasingly, the Company was also able to complement those efforts with good progress in its Energy division, aligning with the Board’s strategy to leverage AnteoTech’s technology advantages into a multi-channel revenue model. The Company is working with global collaborators and regulatory bodies that are understandably very considered and precise when considering new technologies. As such, we need to be somewhat patient to ensure we deliver the most sustainable, commercial outcome for shareholders.

I thank our investors for their ongoing support and look forward to presenting more exciting updates in the time ahead.”

Hold on tight guys....